ArticleEuropean heart journal open2026

Finerenone vs. spironolactone to reduce adverse outcomes in patients with cardiac-kidney-metabolic syndrome complicated by atrial fibrillation: findings from the Tianjin atrial fibrillation project.

Xu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.